These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33383217)

  • 21. MicroRNA-29a represses osteoclast formation and protects against osteoporosis by regulating PCAF-mediated RANKL and CXCL12.
    Lian WS; Ko JY; Chen YS; Ke HJ; Hsieh CK; Kuo CW; Wang SY; Huang BW; Tseng JG; Wang FS
    Cell Death Dis; 2019 Sep; 10(10):705. PubMed ID: 31543513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sexual Dimorphism in MAPK-Activated Protein Kinase-2 (MK2) Regulation of RANKL-Induced Osteoclastogenesis in Osteoclast Progenitor Subpopulations.
    Herbert BA; Valerio MS; Gaestel M; Kirkwood KL
    PLoS One; 2015; 10(5):e0125387. PubMed ID: 25946081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis.
    Kim Y; Sato K; Asagiri M; Morita I; Soma K; Takayanagi H
    J Biol Chem; 2005 Sep; 280(38):32905-13. PubMed ID: 16046394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Schisandrin A restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling.
    Ni S; Qian Z; Yuan Y; Li D; Zhong Z; Ghorbani F; Zhang X; Zhang F; Zhang Z; Liu Z; Yu B
    Cell Prolif; 2020 Oct; 53(10):e12882. PubMed ID: 32871020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternative NF-κB Regulates RANKL-Induced Osteoclast Differentiation and Mitochondrial Biogenesis via Independent Mechanisms.
    Zeng R; Faccio R; Novack DV
    J Bone Miner Res; 2015 Dec; 30(12):2287-99. PubMed ID: 26094846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual Oxidase Maturation Factor 1 Positively Regulates RANKL-Induced Osteoclastogenesis via Activating Reactive Oxygen Species and TRAF6-Mediated Signaling.
    Cheon YH; Lee CH; Jeong DH; Kwak SC; Kim S; Lee MS; Kim JY
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MLN64 deletion suppresses RANKL-induced osteoclastic differentiation and attenuates diabetic osteoporosis in streptozotocin (STZ)-induced mice.
    Lei C; Xueming H; Ruihang D
    Biochem Biophys Res Commun; 2018 Nov; 505(4):1228-1235. PubMed ID: 30322615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic regulation of osteoclast differentiation.
    Yasui T; Hirose J; Aburatani H; Tanaka S
    Ann N Y Acad Sci; 2011 Dec; 1240():7-13. PubMed ID: 22172033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
    Zhang Z; Jimi E; Bothwell AL
    J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCCTC-Binding Factor Translates Interleukin 2- and α-Ketoglutarate-Sensitive Metabolic Changes in T Cells into Context-Dependent Gene Programs.
    Chisolm DA; Savic D; Moore AJ; Ballesteros-Tato A; León B; Crossman DK; Murre C; Myers RM; Weinmann AS
    Immunity; 2017 Aug; 47(2):251-267.e7. PubMed ID: 28813658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCAAT/Enhancer-binding Protein α (C/EBPα) Is Important for Osteoclast Differentiation and Activity.
    Jules J; Chen W; Feng X; Li YP
    J Biol Chem; 2016 Jul; 291(31):16390-403. PubMed ID: 27129246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycyrrhizin Suppresses RANKL-Induced Osteoclastogenesis and Oxidative Stress Through Inhibiting NF-κB and MAPK and Activating AMPK/Nrf2.
    Li Z; Chen C; Zhu X; Li Y; Yu R; Xu W
    Calcif Tissue Int; 2018 Sep; 103(3):324-337. PubMed ID: 29721581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
    Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH
    Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium hydrosulfide inhibits the differentiation of osteoclast progenitor cells via NRF2-dependent mechanism.
    Gambari L; Lisignoli G; Cattini L; Manferdini C; Facchini A; Grassi F
    Pharmacol Res; 2014 Sep; 87():99-112. PubMed ID: 24998607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helvolic acid attenuates osteoclast formation and function via suppressing RANKL-induced NFATc1 activation.
    Chen K; Yuan Y; Wang Z; Song D; Zhao J; Cao Z; Chen J; Guo Q; Chen L; Tickner J; Xu J
    J Cell Physiol; 2019 May; 234(5):6477-6488. PubMed ID: 30341897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Technetium-99 conjugated with methylene diphosphonate inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis.
    Gong W; Dou H; Liu X; Sun L; Hou Y
    Clin Exp Pharmacol Physiol; 2012 Oct; 39(10):886-93. PubMed ID: 23013134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ameloblastin attenuates RANKL-mediated osteoclastogenesis by suppressing activation of nuclear factor of activated T-cell cytoplasmic 1 (NFATc1).
    Chaweewannakorn W; Ariyoshi W; Okinaga T; Fujita Y; Maki K; Nishihara T
    J Cell Physiol; 2019 Feb; 234(2):1745-1757. PubMed ID: 30105896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pueraria lobate Inhibits RANKL-Mediated Osteoclastogenesis Via Downregulation of CREB/PGC1β/c-Fos/NFATc1 Signaling.
    Park KH; Gu DR; Jin SH; Yoon CS; Ko W; Kim YC; Lee SH
    Am J Chin Med; 2017; 45(8):1725-1744. PubMed ID: 29121799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression.
    Zhao Z; Hou X; Yin X; Li Y; Duan R; Boyce BF; Yao Z
    PLoS One; 2015; 10(8):e0135728. PubMed ID: 26287732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.
    Sakai E; Aoki Y; Yoshimatsu M; Nishishita K; Iwatake M; Fukuma Y; Okamoto K; Tanaka T; Tsukuba T
    Phytomedicine; 2016 Jul; 23(8):828-37. PubMed ID: 27288918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.